Bladder, Kidney and Genitals
-
Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer
This is plain language summary provides an overview of the HERO study looking at how well relugolix works, compared with leuprolide, in men with advanced prostate cancer.
-
Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial
The latest plain language summary of publication (PLSP) published in Future Oncology provides a summary of the ARAMIS trial.